Evidence fromstudies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes
Edward T. Wargent, Mohamed S. Zaibi, Jacqueline F. O'Dowd, Michael A. Cawthorne, Steven J. Wang, Jonathan R.S. Arch*, Claire J. Stocker
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Evidence fromstudies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes'. Together they form a unique fingerprint.